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ABSTRACT
Interference with genes is the foundation of reverse
genetics and is key to manipulation of living cells for
biomedical and biotechnological applications. How-
ever, classical genetic knockout and transcriptional
knockdown technologies have different drawbacks
and offer no control over existing protein levels.
Here, we describe an efficient genome editing ap-
proach that affects specific protein abundances by
changing the rates of both RNA synthesis and pro-
tein degradation, based on the two cross-kingdom
control mechanisms CRISPRi and the N-end rule for
protein stability. In addition, our approach demon-
strates that CRISPRi efficiency is dependent on en-
dogenous gene expression levels. The method has
broad applications in e.g. study of essential genes
and antibiotics discovery.
INTRODUCTION
The combined impact of synthesis and degradation dynam-
ically determines protein levels in living cells. There is a
growing need for synthetic biology tools that can control
the abundance of specific proteins, e.g. for the fine-tuning of
enzymes in metabolic pathways or studies of essential genes
for which genetic knockouts are lethal (1). Existing meth-
ods typically focus either on genetic knockouts, conditional
repression of transcription or direct interference with pro-
tein function or stability. However, a combination of these
approaches is desirable to achieve amore controllable, rapid
or stronger repression of the amount of selected proteins in
the cell. Furthermore, for conditional removal of proteins,
stability is a key factor even in fast-growing microbes such
as yeast where the majority of proteins are very long-lived
(2).
Given the recent rapid development in synthetic biology
and genome editing technologies, we asked to what extent it
was possible to harness generic molecular mechanisms for
simultaneously controlling both protein synthesis and sta-
bility. To this end we first looked for a cross-kingdom pro-
tein regulatory mechanism. The N-end rule states that the
identity of the N-terminal residue (N-degron) of a protein
is a prime determinant of its half-life across all kingdoms
of life (3). Conveniently, the tobacco etch virus (TEV) pro-
tease can accommodate most amino acid residues in the P1’
position following the cleavage site (ENLYFQ↓X, where X
denotes all amino acids except proline) and thus this small
recognition site can mask an N-degron (4,5), and we noted
that the N-terminal location enables simultaneous manipu-
lation of the translational initiation region (TIR) - a region
surrounding the start codon that has a major impact on
gene expression levels (6,7). This enables manipulation of
both protein degradation and translation initiation, which
is important when manipulating essential genes as shown
later.
The CRISPR–Cas9 system enables cutting of very spe-
cific DNA sequences in a wide variety of living organisms
and has revolutionized our ability to edit genetic informa-
tion (8). The system has also been repurposed to regulate
transcription––e.g. to activate (9) or repress gene expres-
sion in e.g. Escherichia coli (10), Bacillus subtilis (11), hu-
man cells (12) and Saccharomyces cerevisiae (13) in a gen-
eral approach known as CRISPR interference (CRISPRi).
CRISPRi is based on a catalytically inactive Cas9 endonu-
clease (dCas9), which can interfere with transcription by
binding to specific DNA sequences with the aid of a guide
RNA. However, the efficiency of CRISPRi-based systems
is affected by endogenous gene expression levels (9). Thus,
concomitant manipulation of endogenous gene expression
levels may expand the applicability of CRISPRi. Here, we
develop a single workflow that combines conditional pro-
tein degradation with CRISPRi and TIRmanipulation and
apply the system to study essential genes and develop strains
hypersensitive to antibiotics.
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MATERIALS AND METHODS
Plasmid construction
The pPROTi plasmid resulted from a triple PCR-fragment
assembly via USER cloning, as described previously (14).
For further details on all the plasmids described here
see Supplementary Table S1. We amplified the pSEVA33
backbone, the L-rhamnose inducible promoter PrhaBAD,
and the S219D mutant of TEV protease from pSEVA331
(15), pKS1 (16) and pKM586 (17) with the oligonucleotides
oMSB1270/1267, oMSB1268/1269 and oMSB1271/1273,
respectively. For further details on all the oligonucleotides
described here see Supplementary Table S2. The pMAZ-
SK plasmid with different guide RNAs used to PROTi
tag essential genes by CRMAGE were constructed by
USER cloning (18). This was done by mixing two annealed
oligonucleotides that were complement to the amplified
pMAZ-SK backbone after USER treatment, as described
previously (19). Specifically, for the genes accD, fabG, ftsZ,
glmS, ileS, murE, pheS, ribD, prfB, rnpA, tmk, acpS, ispH,
murA, dapE, lpxC and ribE, the oligonucleotide pairs
oMSB2565/2566, oMSB2591/2592, oMSB2569/2570,
oMSB2571/2572, oMSB2573/2574, oMSB2575/2576,
oMSB2577/2578, oMSB2593/2594, oMSB2579/2580,
oMSB2583/2584, oMSB2585/2586, oMSB2750/2551,
oMSB2740/2741, oMSB2742/2743, oMSB2748/2749,
oMSB2744/2745 and oMSB2746/2747 were used, re-
spectively. To construct the pCRiPi plasmid, the pPROTi
plasmid was PCR amplified using the oligonucleotide pair
oMSB1865/2312, and the dCas9 gene (including the aTc
promoter and the terminator) was amplified from pdCas9
with the oligonucleotides oMSB2313/oMSB1866. For
construction of the pgRNA-CRiPi plasmid targeting the
PROTi tag for the CRiPi system, the pSLQ1236 (Sup-
plementary Table S1) was used as backbone. The gRNA
was changed by standard Gibson assembly (20) with
oligonucleotides oSONG145/146. Nucleotide sequences of
pPROTi, pCRiPi and pgRNA-CRiPi are provided in the
supplementary information.
Bacterial strains, media and growth conditions
The parental strain for all experiments was E. coliMG1655
(ATCC 47076). E. coli MG1655 with GFP integrated into
the genome (21) was initially used to tag gfp first by re-
combineering (22) with the ssDNAMAGE oligonucleotide
oMSB1277 and then with the ssDNA MAGE oligonu-
cleotides oMSB1275 (unstable GFP variant with pheny-
lalanine as the N-degron) or oMSB1276 (stable GFP vari-
ant with alanine). These two GFP variants were used as
PCR templates to add the IPTG inducible T5 promoter
with the oligonucleotides oMSB1661 and oMSB1662. Af-
ter, T5-GFP variants were integrated into the E. coli
MG1655 genome by clonetegration (23), using pOSIP-KT,
and the oligonucleotides oMSB1297 and oMSB1298. FLP-
mediated excision was performed as previously described
(23). All E. coli strains were grown in lysogeny broth (LB)
at 37◦C shaking at 300 rpm. The antibiotics ampicillin (100
g/mL), chloramphenicol (30 g/ml) or kanamycin (50
g/ml) were added when needed. gfp expression was in-
duced with 0.1 mM IPTG; tev protease expression was in-
duced with 5 mM rhamnose; and dCas9 endonuclease ex-
pression was induced with 200 ng/ml aTc.
Genomic integration of the PROTi tag
The PROTi tag was inserted after the first codon down-
stream of the start codon in genes of interest, according
to the previously described CRMAGE protocol (19).
The starting strain for CRMAGE was MG1655 K-12
harboring the pMA7CR 2.0 and pZS4Int-tetR plasmids.
The pMA7CR 2.0 plasmid expresses the Cas9 nuclease,
the -red -proteins and the dam protein that represses
the mismatch DNA repair system for obtaining higher
genome editing efficiency (19) 5M of ssDNA CRMAGE
oligonucleotide and 250 ng of pMAZ-SK plasmid with in-
serted gRNA were used for electroporation. Cultures were
grown at 37◦C in Julabo SW22 linear-shaking water-bath
at 250 rpm. After aTc addition to express Cas9 according
to the previously published protocol (19), recovery was per-
formed overnight. The ssDNA CRMAGE oligonucleotide
contained 35–45 nucleotide end homology on each side of
the insertion. For each gene, a PAM sequence (5′-NGG-3′)
and the adjacent gRNA (20 nucleotides) were chosen
in the coding sequence. The pMAZ-SK plasmids with
inserted gRNA were constructed as described above. One
nucleotide in the PAM sequence was changed in the ssDNA
CRMAGE oligonucleotide to avoid Cas9 recognition of
mutants with the inserted PROTi tag. Randomization of
the TIR was done by changing the specific nucleotides in
the ssDNA CRMAGE oligonucleotide used for insertion
of the PROTi tag. For the genes accD, fabG, ftsZ, glmS,
ileS, murE, pheS, ribD, prfB, rnpA, tmk, acpS, ispH, murA,
dapE, lpxC and ribE, the ssDNA CRMAGE oligonu-
cleotides oMSB2595, oMSB2596, oMSB2597, oMSB2598,
oMSB2599, oMSB2600, oMSB2601, oMSB2651,
oMSB2602, oMSB2603, oMSB2604, oMSB2757,
oMSB2752, oMSB2753, oMSB2756, oMSB2754 were
used, respectively.
PROTi characterization
E. coliMG1655 strains containing the PROTi tagged gfp in
the genome and harboring the pPROTi plasmid, were inoc-
ulated from an overnight culture to OD600 0.01 in LB sup-
plemented with chloramphenicol and IPTG. After 4 h of
growing, the cultures were induced by adding 5 mM rham-
nose. To wash out IPTG from the culture medium before
inducing with rhamnose, the cultures were centrifuged and
resuspended in the same volume of LB with chlorampheni-
col and rhamnose. After 1–4 h, cultures were analyzed in a
SynergyMx Microplate reader from Biotek. For GFP flu-
orescence quantification, emission was detected at 512 nm
with the excitation light of 480 nm and 80 level gain.
Flow cytometry
Flow cytometry measurements were performed on a FACS
Aria (Becton–Dickinson, San Jose, USA) with 488 nm exci-
tation from a blue solid-state laser. Cells were diluted 1:100
in PBS for analysis. At least 20 000 cells were collected
for each measurement. FlowJo (Treestar) was used for data
analysis.
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Growth profiles
Growth was monitored in the BioLector® from m2p-labs.
Each of the tagged PROTi clones were diluted 1:100 in 1
ml LB supplied with appropriate antibiotics in a Flower-
Plate (48-well MTP, flower) for the BioLector®. Cultures
were induced with rhamnose and aTc from the beginning
of growth and grown at 37◦C, shaking at 1200 rpm.
CFU assays and drop tests
To determine colony forming units (CFU), cultures of
PROTi tagged essential genes harboring the pPROTi plas-
mid were inoculated in 1 ml LB supplied with chloram-
phenicol and rhamnose in a 96-well microtiter plate. After 4
h of growth, cultures were plated on LB agar plates in serial
dilutions. For the CRiPi system, cultures were inoculated in
1 ml LB supplied with chloramphenicol and ampicillin and
grown for 4 h. The CRiPi system was induced with rham-
nose and aTc and the cultures were grown for additional 4 h
before plating. For drop tests, overnight cultures of tagged
essential gene variants were diluted to the same OD and 10-
fold serial dilutions were performed. From each dilution, 10
l were placed on LB agar plates with appropriate antibi-
otics.
Fosfomycin sensitivity
Fosfosmycin sensitivity was determined with minimum
inhibitory concentration (MIC) assays as previously de-
scribed (24). Stock solution of fosfomycin disodium (Sigma
Aldrich) salt was dissolved in MiliQ water (1 mg/ml).
Briefly, 2-fold serial dilutions of antibiotic stocks (from
0.015 to 256 g/l) were made in 150 l LB medium sup-
plemented with the appropriate antibiotics, rhamnose and
aTc (for CRiPi-induction) and OD after 18 h was deter-
mined and plotted relative to the growth of the same cells in
the absence of fosfomycin. For testing fosfomycin sensitiv-
ity upon PROTi induction, cultures of murE1-tagged cells
harbouring the CRiPi system were inoculated in 1 ml LB
supplied with chloramphenicol, ampicillin and rhamnose in
a 96-well microtiter plate. After 4 h of growth, cultures were
plated on LB agar plates supplied with different concentra-
tions of fosfomycin.
RESULTS
We first engineered a pro-N-degron module by incorporat-
ing the corresponding nucleotide sequence at the 5′ end
of a gene on the E. coli chromosome using CRMAGE
genome editing (19). The pro-N-degron module consists of
a seven amino acid peptide recognition site of the tobacco
etch virus (TEV) protease (ENLYFQ↓F) (5) and an eleven
amino acid-linker (25). In the presence of TEV protease, the
peptide is cleaved and an N-end-rule substrate is generated
with phenylalanine as the prime protein-destabilizing factor
(Figure 1A). Importantly, the entire coding sequence for the
pro-N-degron module is small enough to fit into a standard
oligonucleotide compatible with CRMAGE.With this pro-
tein interference (PROTi) system, by rhamnose-inducible
expression of the TEV protease from a plasmid, the N-
degron becomes de-protected and the protein is targeted for
proteasomal degradation through the N-end rule pathway.
To characterize the system, the PROTi tag was fused to
the N-terminus of GFP by integrating the coding sequence
into the E. coli genome with a synthetic IPTG-inducible
T5 promoter (Figure 1A). In the resulting strain, GFP pro-
duction was induced by adding IPTG followed by growth
for four hours. At this stage, expression of the TEV pro-
tease was induced with rhamnose. Three hours after ad-
dition of rhamnose, GFP levels showed a strong decrease
(83%––measured by whole cell fluorescence) compared to
the uninduced control (Figure 1B). Further characteriza-
tion of the system by flow cytometry revealed a broad pop-
ulation of cells with different fluorescence levels upon in-
duced protein degradation (Figure 1C), which we hypoth-
esized was caused by simultaneous strong GFP synthesis
driven by the T5 promoter.Washing out IPTG from the cul-
ture medium prior to the induction of the PROTi system
with rhamnose confirmed this hypothesis as it resulted in a
homogeneous non-fluorescent population (Figure 1D). The
reduction in GFP fluorescence can be ascribed to the gen-
erated N-degron, since GFP fluorescence remained high in
cells harboring a stable PROTi tag variant, with the pheny-
lalanine of the N-degron replaced by an alanine (Figure
1D).
The fact that protein abundance is a function of both syn-
thesis and stability prompted us to turn to the broadly ap-
plicable CRISPR–Cas9-based gene regulation technology.
With the aim of gaining control over both transcription and
protein stability with a single genome-editing step, we devel-
oped a CRISPRi–PROTi (CRiPi) system, where dCas9 can
be produced together with the TEV protease (Figure 2A),
thereby enabling simultaneous inhibition of gene expression
as well as degradation of the target protein.
Based on previous studies, the gRNA was designed to
bind to the non-template DNA in the 5′ end of the gene,
and dCas9was expressed from a plasmid with an anhydrous
tetracycline (aTc)-inducible promoter (10). Moreover, we
designed the gRNA so that it only targets the CRMAGE-
inserted sequence, which encodes the TEVprotease recogni-
tion site and the N-degron-linker, thereby creating a generic
gRNA target independent from the site of insertion (Figure
2A).
As shown in Figure 2B, cellular depletion of GFP was
rapidly achieved with high efficiency when the CRiPi sys-
tem was induced with both rhamnose and aTc. Specifically,
76% of the cells showed complete loss of fluorescence after
two hours of induction. In contrast, the induction of dCas9
expression alone caused only a slightly reduced GFP fluo-
rescence, denoting the high stability of GFP (Figure 2B).
The technology described above is particularly useful for
analysis of genes that are essential for the organism and thus
inaccessible with traditional knockout approaches. Thus,
to further demonstrate the functionality of the system, we
compared the effectiveness of the PROTi, CRISPRi and
CRiPi technologies to control the level of proteins encoded
by essential genes in E. coli. In a previous approach all es-
sential genes in E. coli were individually targeted with a se-
quence encoding a C-terminal protein degradation tag (mf-
ssrA) but 67 proteins could not be tagged this way despite
repeated attempts (26). We noted that 54 of these 67 ‘inac-
cessible’ genes were part of operons, making lethal polar ef-
fects a likely explanation. Thus, the N-terminal location of
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Figure 1. PROTi:Development and characterization of the PROTi system to control protein abundances. (A) Schematic illustration of the PROTi system.
The coding sequence for the pro-N-degron module (orange) is integrated by CRMAGE at the 5′-end of a genomically integrated gfp (green). gfp is under
control of the IPTG-inducible T5 promoter. With PROTi, the TEV protease (blue) is expressed from the PrhaBAD promoter leading to de-protection of
the N-degron followed by degradation of GFP (green) through the N-end rule pathway. (B) Whole-cell fluorescence measurement of cells expressing GFP
tagged with the pro-N-degron––with and without the PrhaBAD inducer rhamnose (Rham). Data represents the average of three biological replicates and
bars show the standard error. (C) Flow cytometry histogram displaying the fluorescence signals after 0, 2, 3 or 4 h induction with rhamnose or without
induction (Ø). (D) Fluorescence signals after 3 h of PROTi induction with rhamnose, while removing the IPTG inducer from the culture medium by
washing. A stable PROTi tag with alanine (Ala) replacing phenylalanine was included as control.
the PROTi tag could enable the targeting of some of these
essential genes and since the inserted module overlaps with
the TIR, expression tuning by nucleotide variation in this
region could minimize polar effects caused by e.g. changes
in translational speed.
Using CRMAGE, we attempted targeting of ten essen-
tial genes that were not previously mf-ssrA-tagged (glmS,
ileS, murE, pheS, ribD, tmk, accD, prfB, fabG and rnpA)
and seven that were previously mf-ssrA-tagged (ftsZ, acpS,
ispH, murA, dapE, lpxC and ribE) (26) using the pro-N-
degron module designed with a TIR library made of six
random nucleotides upstream from the start codon and all
synonymous codons sampled in two positions following the
start codon (Figure 3A). Remarkably, this way we were able
to identify insertions in seven of the 10 genes that were not
previously mf-ssrA-tagged, despite their location in essen-
tial operons––as well as three out of the seven previously
mf-ssrA-tagged genes (Supplementary Table S3). Not sur-
prisingly, we also noted a high variability in colony size di-
rectly after CRMAGE, and in cell viability assays (Supple-
mentary Figure S1), as a directly observable consequence of
the TIR variation. This is highly useful both for gauging the
success rate of CRMAGE and when searching for variants
with wild type gene expression levels. For example, for ileS,
11 small colonies were screened by colony PCR and all had
the PROTi tag inserted. From 12 big colonies, 11 were neg-
ative. For the rnpA gene, five out of 12 small colonies were
positive, whereas 10 out of 11 of the big colonies were not
tagged.
To demonstrate the value of the TIR variation approach,
for five of the genes (murE, pheS, rpnA, ileS and ribD), we at-
tempted to insert the corresponding sequences without TIR
variation – preserving the six nucleotides upstream from the
start codon from the native gene context. For three of these
genes we were unable to isolate tagged clones, indicating a
lethal effect, whereas we could isolate clones with the ileS
and rnpA genes tagged (Figure 3B and C). However, these
clones clearly exhibited growth defects both directly after
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Figure 2. CRiPi: Schematic illustration of the CRISPRi-PROTi (CRiPi) system. (A) Cellular depletion of the targeted protein can be accelerated by simul-
taneous expression of dCas9 (red) from the Ptet promoter and the TEV protease (blue) from the PrhaBAD promoter. Here shown for gfp as an example.
The dCas9 targets the genomically integrated pro-N-degron encoding sequence with the aid of a guide RNA (gRNA, brown, curved line) and represses
transcription. (B) Fluorescence after 3 h of PROTi, PROTi and wash, CRISPRi, or CRiPi induction with rhamnose and the Ptet inducer anhydrous
tetracycline (aTc), or with no induction (Ø).
CRMAGE and in subsequent viability tests (Figure 3B and
C). In contrast, using the TIR randomization approach, we
were able to isolate tagged gene variants without any ob-
servable growth defects.
After having obtained both growth-affected and unaf-
fected PROTi-tagged gene variants, we moved on to study
the CRiPi system, by inducing protein degradation and/or
gene silencing. Most of the strains were unaffected in
growth in liquid cultures after PROTi induction with rham-
nose (Supplementary Figure S2). In fact, rhamnose had a
small stimulatory effect on growth in several cases (Supple-
mentary Figure S2). However, the tagged murE, ribD and
pheS strains exhibited 1–2 orders of magnitude decrease in
viability when plating the cells after PROTi induction (Fig-
ure 3D) and most of the strains showed growth retardation
after CRISPRi induction with aTc (Supplementary Figure
S2). Only the taggedmurE strain showed a clear effect when
inducing PROTi directly in liquid culture (Figure 3E). Of
the two approaches utilized in the CRiPi method, CRISPRi
had the strongest overall effect (Supplementary Figure S2).
However, for the ileS and pheS-strains the repression of
growth after plating was clearly enhanced by simultaneous
targeting of both transcription and protein stability (Fig-
ure 3F), thereby showing the versatility and strength of the
CRiPi method.
To demonstrate the relevance of CRiPi and PROTi for
applied biotechnology, we explored its performance as a
tool for creating antibiotic hypersensitive strains for use
in antibiotic discovery. When screening large compound
libraries it is challenging to supply sufficiently high con-
centrations of each compound, which leads to false neg-
atives in the screen. Lowering the concentration of essen-
tial protein targets, enable high-throughput screening with
sub-inhibitory drug concentrations and discovery of com-
binatorial drugs and targets (27). We focused on MurE, a
central enzyme in peptidoglycan biosynthesis (Figure 3G).
When CRiPi or PROTi were induced in cells harboring
PROTi-tagged MurE, a significant decrease in viability was
observed (Figure 3D and H). We next demonstrated murE
as a potential target for creating hypersensitive strains that
can be used for screening compound libraries to identify
agents with antibacterial activity. Fosfomycin is an antibi-
otic that causes specific inhibition of the enzyme MurA,
which is involved in the same peptidoglycan biosynthetic
pathway as MurE (Figure 3G). By applying fosfomycin to
cells with an induced CRiPi or PROTi system targeting
MurE, the sensitivity to the antibiotic increased, depicted as
complete growth inhibition at lower concentrations of the
antibiotic, compared to the non-induced control (Figure 3I
and Supplementary Figure S3). Moreover, fosfomycin sen-
sitivity varied markedly in clones with different murE-TIR
backgrounds upon induction of CRiPi (Figure 3I and Sup-
plementary Figure S4).
DISCUSSION
Our approach has some limitations: N-terminal peptide
tagging of essential proteins may not always be allowed as
the tag itself could compromise activity. Furthermore, when
attached to some proteins, TEV cleavage or subsequent tar-
geting to the ClpP protease may not be efficient. However,
PROTi could serve as a complement to other protein desta-
bilizing technologies (e.g. proteins that are compromised by
C-terminal tagging). Here, we were able to target 7 out of 10
proteins that previously had failed with a C-terminal desta-
bilizing tag approach. It is possible that an even higher suc-
cess rate could be obtained with additional screening efforts
(and almost certainly for targeting of non-essential genes).
Four out of these seven proteins (encoded by murE, ribD,
ileS and pheS) were sensitive to induction of PROTi.
CRISPRi generally had the highest growth-effect on es-
sential genes, compared to PROTi, possibly due to the re-
duced affinity of TEV protease with the N-end rule sub-
strate Phe in the P1’ position (5) or because essential protein
depletion is compensated for by gene expression upregula-
tion. The approach could potentially benefit from increas-
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Figure 3. PROTi, CRiPi and TIR randomization can control protein levels and produce antibiotic hypersensitive bacteria. (A) Randomization of the
translation initiation region (TIR, red font) in a ssDNA oligonucleotide enables CRMAGE-based insertion of the PROTi tag (orange) containing the TEV
protease recognition site (blue) in genes of interest (GOI). (B) CRMAGE cultures plated directly after insertion of the PROTi tag in ileS (left) and rnpA
(right) genes without TIR variation. Note the presence of both small and large colonies. The small colonies contained the PROTi tagged gene variants, as
verified by colony PCR. (C) Drop tests of cells with ileS and rnpA tagged with and without TIR variation (rt: randomized TIR, nt: non-random TIR). TIR
region sequences are indicated next to the different drop test lanes - red font indicates nucleotides different from the wild type sequence, blue font highlights
the TEV protease recognition site and the start codon is highlighted in green. (D) Viability of control strain (WT with the PROTi plasmid) and PROTi
variants tagged in the essential E. coli genes murE, ribD and pheS with and without rhamnose (Rham) induction. (E) Growth profile of murE-rt1 cells
carrying the PROTi system with and without Rham induction. (F) Agar plates illustrating the effect of ileS- and pheS-tagged cells with CRISPRi (aTc),
PROTi (Rham) or CRiPi (aTc + Rham) induced after 4 h and plated after an additional 4 h of growth. Without inducers (Ø) growing bacteria completely
cover the plate. (G) Illustration of the Mur enzymes involved in peptidoglycan biosynthesis pathway. (H) Growth profile of uninduced murE-rt1 cells (Ø)
or induced with Rham and/or aTc. (I) Fosfomycin sensitivity upon CRiPi induction in murE-tagged clones or no induction (Ø). Growth was tested in
increasing concentrations of fosfomycin after 18 h incubation. All values are the averages of three biological replicates and bars show standard error.
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ing the in vivo TEV protease activity, or by increasing the
activity of the endogenous ClpA/P/S factors as shown pre-
viously in a similar system (29).
We were initially surprised by the almost complete lack
of effect of PROTi in log phase cultures whereas subsequent
plating resulted in several orders of magnitude reduction in
growth for some of the PROTi targeted essential gene prod-
ucts. A similar observation was made recently in a high-
throughput targeting of essential genes with CRISPRi in B.
subtilis (11). There, it was suggested that (essential) protein
levels are important for outgrowth from stationary phase,
whereas maximal growth rate in log phase is less affected. It
is possible that our CRISPRi system is more efficient than
the one described for Bacillus, whereas the weaker effect of
PROTi more resembles the Bacillus CRISPRi efficiency.
By inserting the sequence as a TIR variation library it is
possible to create expression variants that can be screened
with minimal polar effects, mimicking the natural gene ex-
pression level. Furthermore, some of the TIR variants, e.g.
rnpA-rt1 and rnpA-rt1 (Supplementary Figure S2) ormurE-
rt1 and murE-rt2 (Figure 3H and Supplementary Figure
S2) varied significantly in their sensitivity to CRISPRi, pro-
viding further support for the relationship between gene
expression and CRISPRi efficiency (9). Thus, this type of
multi-level reverse genetics toolmay further expand the util-
ity of the highly successful CRISPR/Cas system.
Bacterial antibiotic resistance is rapidly exhausting the
number of available effective antimicrobial agents. Con-
sequently, there is an urgent need to identify new target-
specific inhibitors to develop antimicrobial compounds
(28). With our combined CRiPi approach, insertion of a
simple and inexpensive oligonucleotide enables subtle tun-
ing of potential antibiotic targets on both the transcrip-
tional and posttranslational level. Furthermore, the system
represents a unique and versatile workflow that may enable
future in-depth characterization of essential genes located
in operons.
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